Group One Trading’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $45.4K | Buy |
+200
| New | +$35.6K | ﹤0.01% | 5463 |
|
|
2025
Q4 | – | Sell |
-1,000
| Closed | -$156K | – | 8273 |
|
|
2025
Q3 | $156K | Sell |
1,000
-1,200
| -55% | -$191K | ﹤0.01% | 4932 |
|
|
2025
Q2 | $334K | Sell |
2,200
-10,700
| -83% | -$1.43M | ﹤0.01% | 3813 |
|
|
2025
Q1 | $1.94M | Sell |
12,900
-3,900
| -23% | -$654K | 0.01% | 1833 |
|
|
2024
Q4 | $3.1M | Hold |
16,800
| – | – | 0.01% | 1537 |
|
|
2024
Q3 | $3.31M | Buy |
16,800
+200
| +1% | +$41.6K | 0.01% | 1334 |
|
|
2024
Q2 | $3.43M | Buy |
+16,600
| New | +$3.76M | 0.01% | 1034 |
|
|
2023
Q3 | – | Sell |
-7,500
| Closed | -$1.58M | – | 7731 |
|
|
2023
Q2 | $1.58M | Buy |
7,500
+1,100
| +17% | +$219K | 0.01% | 1935 |
|
|
2023
Q1 | $1.29M | Sell |
6,400
-40,100
| -86% | -$9.09M | ﹤0.01% | 1916 |
|
|
2022
Q4 | $10.1M | Buy |
+46,500
| New | +$10.2M | 0.02% | 731 |
|
|
2022
Q2 | – | Sell |
-37,200
| Closed | -$10.6M | – | 7918 |
|
|
2022
Q1 | $10.6M | Buy |
37,200
+37,000
| +18,500% | +$11.4M | 0.01% | 959 |
|
|
2021
Q4 | $75K | Buy |
+200
| New | +$77.7K | ﹤0.01% | 5980 |
|
|
2021
Q3 | – | Sell |
-400
| Closed | -$148K | – | 8241 |
|
|
2021
Q2 | $148K | Sell |
400
-1,400
| -78% | -$467K | ﹤0.01% | 5555 |
|
|
2021
Q1 | $522K | Buy |
1,800
+800
| +80% | +$222K | ﹤0.01% | 3981 |
|
|
2020
Q4 | $250K | Buy |
+1,000
| New | +$238K | ﹤0.01% | 3893 |
|
|
2019
Q2 | – | Sell |
-3,000
| Closed | -$436K | – | 5018 |
|
|
2019
Q1 | $436K | Hold |
3,000
| – | – | ﹤0.01% | 2055 |
|
|
2018
Q4 | $340K | Buy |
+3,000
| New | +$376K | ﹤0.01% | 2267 |
|
|
2016
Q1 | – | Sell |
-6,800
| Closed | -$547K | – | 4609 |
|
|
2015
Q4 | $547K | Hold |
6,800
| – | – | 0.01% | 1753 |
|
|
2015
Q3 | $432K | Buy |
6,800
+5,300
| +353% | +$381K | 0.01% | 1893 |
|
|
2015
Q2 | $106K | Buy |
+1,500
| New | +$111K | ﹤0.01% | 3036 |
|
|
2014
Q3 | – | Sell |
-3,000
| Closed | -$161K | – | 5172 |
|
|
2014
Q2 | $161K | Sell |
3,000
-4,500
| -60% | -$247K | ﹤0.01% | 2590 |
|
|
2014
Q1 | $453K | Buy |
7,500
+2,900
| +63% | +$169K | 0.01% | 1714 |
|
|
2013
Q4 | $244K | Buy |
4,600
+1,200
| +35% | +$60.3K | ﹤0.01% | 2255 |
|
|
2013
Q3 | $157K | Buy |
3,400
+300
| +10% | +$13.8K | ﹤0.01% | 2602 |
|
|
2013
Q2 | $127K | Buy |
+3,100
| New | +$133K | ﹤0.01% | 2588 |
|
Other funds holding CRL
AI
Group One Trading's CRL Position: Q2 2026 in Review
Group One Trading increased its Charles River Laboratories (CRL) stake by 1,997% in Q2 2026, buying an estimated $267K and bringing the position to 1,573 shares worth $357K. The position accounts for ﹤0.01% of the portfolio, ranked #3810.
Group One Trading first reported a position in CRL in Q2 2013 and has held it in 24 quarters since. The position peaked at $1.61M in Q1 2025. 569 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- Group One Trading held 1,573 shares of Charles River Laboratories worth $357K as of Q2 2026.
- Group One Trading bought 1,498 Charles River Laboratories shares in Q2 2026, an estimated $267K.
- Charles River Laboratories made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #3810 holding.
- Group One Trading first reported a position in Charles River Laboratories in Q2 2013 and has held it in 24 quarters since.
- Group One Trading's Charles River Laboratories position peaked at $1.61M in Q1 2025.
- 569 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.